MicroRNA and diffuse large Bcell lymphoma

doi:10.3760/cma.j.issn.1673422X.2014.06.019

Journal of International Oncology ›› 2014, Vol. 41 ›› Issue (6): 463-466.doi: 10.3760/cma.j.issn.1673422X.2014.06.019

Previous Articles Next Articles

MicroRNA and diffuse large Bcell lymphoma

Wang Xinyuan*, Yang Xigui, Jiang Chao

*School of Medical and Life Sciences, Shandong Academy of Medical Sciences, Jinan University; Department of Medical Oncology, Shandong Cancer Hospital, Jinan 250117, China

Online:2014-06-08 Published:2014-05-08
Contact: Yang Xigui E-mail:zlysxgy@126.com

Abstract

Abstract: MicroRNA (miRNA) is a kind of naturally occurring short noncoding small molecular RNA, which regulates gene expression at the posttranscriptional level through its sequence complementation with target mRNAs. Researches have shown that different malignant tumors, including diffuse large B cell lymphoma, have specific miRNA expression profiles. Therefore, miRNAs expression level of specimens of body fluids and tissues is expected to be the new indicator for assessing diffuse large B cell lymphoma.

Key words: MicroRNAs, Lymphoma, large Bcell, diffuse

WANG Xin-Yuan, YANG Xi-Gui, JIANG Chao. MicroRNA and diffuse large Bcell lymphoma[J]. Journal of International Oncology, 2014, 41(6): 463-466.

[1]	Gong Yan, Chen Honglei. Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer [J]. Journal of International Oncology, 2024, 51(3): 186-190.
[2]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207.
[3]	Yin Yunyan, Li Hui, Li Yuchen, Hui Hui, Xu Jingyan. Clinical application of histone deacetylase inhibitors in non-Hodgkin lymphoma [J]. Journal of International Oncology, 2022, 49(8): 499-504.
[4]	Wang Liuxue, Xi Xiaoping, Liu Jingjing, Shen Guomin, Yang Haiping. Research progress of metformin in non-Hodgkin lymphoma [J]. Journal of International Oncology, 2022, 49(7): 436-440.
[5]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing. MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2 [J]. Journal of International Oncology, 2022, 49(4): 193-198.
[6]	Jin Jiahui, Chen Cunhai, Ma Xuezhen. Effects of radiation-associated miRNA in radiotherapy for breast cancer [J]. Journal of International Oncology, 2022, 49(12): 735-738.
[7]	Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei. Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer [J]. Journal of International Oncology, 2022, 49(11): 681-686.
[8]	Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin. Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis [J]. Journal of International Oncology, 2022, 49(1): 45-50.
[9]	Hong Anlan, Cao Meng, Wang Yan, Fang Fang. Research progress on lncRNAs as members of ceRNA network in melanoma [J]. Journal of International Oncology, 2022, 49(1): 61-64.
[10]	Guo Yiwei, Liu Aichun. Treatment of EB virus positive diffuse large B cell lymphoma [J]. Journal of International Oncology, 2021, 48(7): 385-388.
[11]	Liu Pei, Pu Jiaze, Huang Wen, Wang Fei. Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis [J]. Journal of International Oncology, 2021, 48(7): 409-414.
[12]	Wang Yang, Liu Qian, Long Hui, Wu Qingming. Research status of fecal detection for colorectal cancer markers [J]. Journal of International Oncology, 2021, 48(7): 441-444.
[13]	Cheng Yiming, Li Gang, Wang Zhenming, Lyu Qianwen, Li Shirong. Value of serum miR-196a-5p and miR-105-5p in differential diagnosis of benign and malignant pulmonary nodules [J]. Journal of International Oncology, 2021, 48(5): 282-286.
[14]	Li Qiao'er, Zou Liqun. Stratified therapeutic choices in elderly patients with diffuse large B-cell lymphoma [J]. Journal of International Oncology, 2021, 48(5): 317-320.
[15]	Deng Bo'er, Kong Weimin. Epigenetic research progress of endometrial cancer [J]. Journal of International Oncology, 2021, 48(3): 184-188.

MicroRNA and diffuse large Bcell lymphoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments